Form 8-K - Current report:
SEC Accession No. 0001558370-25-004266
Filing Date
2025-04-01
Accepted
2025-04-01 16:15:11
Documents
14
Period of Report
2025-03-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K elev-20250331x8k.htm   iXBRL 8-K 45575
  Complete submission text file 0001558370-25-004266.txt   178335

Data Files

Seq Description Document Type Size
2 EX-101.SCH elev-20250331.xsd EX-101.SCH 4019
3 EX-101.DEF elev-20250331_def.xml EX-101.DEF 2820
4 EX-101.LAB elev-20250331_lab.xml EX-101.LAB 17916
5 EX-101.PRE elev-20250331_pre.xml EX-101.PRE 11884
16 EXTRACTED XBRL INSTANCE DOCUMENT elev-20250331x8k_htm.xml XML 5048
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 25799820
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)